MedPath

Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment

Phase 3
Completed
Conditions
Diabetes Mellitus, Type 2
Renal Insufficiency
Interventions
Drug: BI 10773
Drug: Placebo
Registration Number
NCT01164501
Lead Sponsor
Boehringer Ingelheim
Brief Summary

This study will investigate the efficacy and safety of the BI 10773 in type 2 diabetic patients with renal impairment in order to provide these data for approval for BI 10773 as an antidiabetic agent by regulatory authorities.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
741
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
BI 10773 low doseBI 10773BI 10773 tablets once daily
BI 10773 low dosePlaceboBI 10773 tablets once daily
BI 10773 high dosePlaceboBI 10773 tablets once daily
BI 10773 high doseBI 10773BI 10773 tablets once daily
PlaceboPlaceboPlacebo tablets matching BI 10773
Primary Outcome Measures
NameTimeMethod
HbA1c Change From Baseline in Patients With Mild or Moderate Renal ImpairmentBaseline and 24 weeks

Change from baseline in HbA1c after 24 weeks, for patients with mild or moderate renal impairment.

Note adjusted means are provided.

HbA1c Change From Baseline in Patients With Mild Renal ImpairmentBaseline and 24 weeks

Change from baseline in HbA1c after 24 weeks, for patients with mild renal impairment.

Note adjusted means are provided.

HbA1c Change From Baseline in Patients With Moderate Renal ImpairmentBaseline and 24 weeks

Change from baseline in HbA1c after 24 weeks, for patients with moderate renal impairment.

Note adjusted means are provided.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (127)

1245.36.10014 Boehringer Ingelheim Investigational Site

๐Ÿ‡บ๐Ÿ‡ธ

Anaheim, California, United States

1245.36.10012 Boehringer Ingelheim Investigational Site

๐Ÿ‡บ๐Ÿ‡ธ

Corpus Christi, Texas, United States

1245.36.31004 Boehringer Ingelheim Investigational Site

๐Ÿ‡ณ๐Ÿ‡ฑ

Den Haag, Netherlands

1245.36.31017 Boehringer Ingelheim Investigational Site

๐Ÿ‡ณ๐Ÿ‡ฑ

Hardenberg, Netherlands

1245.36.20053 Boehringer Ingelheim Investigational Site

๐Ÿ‡จ๐Ÿ‡ฆ

Toronto, Ontario, Canada

1245.36.10004 Boehringer Ingelheim Investigational Site

๐Ÿ‡บ๐Ÿ‡ธ

Greer, South Carolina, United States

1245.36.10017 Boehringer Ingelheim Investigational Site

๐Ÿ‡บ๐Ÿ‡ธ

Plantation, Florida, United States

1245.36.10008 Boehringer Ingelheim Investigational Site

๐Ÿ‡บ๐Ÿ‡ธ

Greenville, North Carolina, United States

1245.36.10002 Boehringer Ingelheim Investigational Site

๐Ÿ‡บ๐Ÿ‡ธ

Houston, Texas, United States

1245.36.10021 Boehringer Ingelheim Investigational Site

๐Ÿ‡บ๐Ÿ‡ธ

Endwell, New York, United States

1245.36.10003 Boehringer Ingelheim Investigational Site

๐Ÿ‡บ๐Ÿ‡ธ

Melrose Park, Pennsylvania, United States

1245.36.10007 Boehringer Ingelheim Investigational Site

๐Ÿ‡บ๐Ÿ‡ธ

San Antonio, Texas, United States

1245.36.10011 Boehringer Ingelheim Investigational Site

๐Ÿ‡บ๐Ÿ‡ธ

Spokane, Washington, United States

1245.36.10023 Boehringer Ingelheim Investigational Site

๐Ÿ‡บ๐Ÿ‡ธ

Renton, Washington, United States

1245.36.10006 Boehringer Ingelheim Investigational Site

๐Ÿ‡บ๐Ÿ‡ธ

Tacoma, Washington, United States

1245.36.20055 Boehringer Ingelheim Investigational Site

๐Ÿ‡จ๐Ÿ‡ฆ

Edmonton, Alberta, Canada

1245.36.20051 Boehringer Ingelheim Investigational Site

๐Ÿ‡จ๐Ÿ‡ฆ

Mississauga, Ontario, Canada

1245.36.20086 Boehringer Ingelheim Investigational Site

๐Ÿ‡จ๐Ÿ‡ฆ

Thornhill, Ontario, Canada

1245.36.33001 Boehringer Ingelheim Investigational Site

๐Ÿ‡ซ๐Ÿ‡ท

Corbeil Essonnes, France

1245.36.33042 Boehringer Ingelheim Investigational Site

๐Ÿ‡ซ๐Ÿ‡ท

Nanterre Cedex, France

1245.36.33041 Boehringer Ingelheim Investigational Site

๐Ÿ‡ซ๐Ÿ‡ท

Nice, France

1245.36.85201 Boehringer Ingelheim Investigational Site

๐Ÿ‡ญ๐Ÿ‡ฐ

Hong Kong, Hong Kong

1245.36.33043 Boehringer Ingelheim Investigational Site

๐Ÿ‡ซ๐Ÿ‡ท

Rennes, France

1245.36.33044 Boehringer Ingelheim Investigational Site

๐Ÿ‡ซ๐Ÿ‡ท

Saint Mandรฉ, France

1245.36.91209 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฎ๐Ÿ‡ณ

Aligarh, Uttar Pradesh, India

1245.36.91205 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฎ๐Ÿ‡ณ

Bangalore, India

1245.36.91201 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฎ๐Ÿ‡ณ

Chennai, India

1245.36.91204 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฎ๐Ÿ‡ณ

Bangalore, India

1245.36.91208 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฎ๐Ÿ‡ณ

Bangalore, India

1245.36.91213 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฎ๐Ÿ‡ณ

Gurgaon, India

1245.36.91203 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฎ๐Ÿ‡ณ

Hyderabad, India

1245.36.91211 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฎ๐Ÿ‡ณ

Kolkata, India

1245.36.91207 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฎ๐Ÿ‡ณ

Pune, India

1245.36.60004 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฒ๐Ÿ‡พ

Pahang, Malaysia

1245.36.60011 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฒ๐Ÿ‡พ

Perak, Malaysia

1245.36.60010 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฒ๐Ÿ‡พ

Pulau Piang, Malaysia

1245.36.44016 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฌ๐Ÿ‡ง

Blackpool, United Kingdom

1245.36.48005 Boehringer Ingelheim Investigational Site

๐Ÿ‡ต๐Ÿ‡ฑ

Torun, Poland

1245.36.44012 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฌ๐Ÿ‡ง

Chesterfield, United Kingdom

1245.36.74008 Boehringer Ingelheim Investigational Site

๐Ÿ‡ธ๐Ÿ‡ฐ

Nove Mesto Nad Vahom, Slovakia

1245.36.74012 Boehringer Ingelheim Investigational Site

๐Ÿ‡ธ๐Ÿ‡ฐ

Presov, Slovakia

1245.36.34021 Boehringer Ingelheim Investigational Site

๐Ÿ‡ช๐Ÿ‡ธ

San Sebastian de los Reyes, Spain

1245.36.70008 Boehringer Ingelheim Investigational Site

๐Ÿ‡ท๐Ÿ‡บ

Moscow, Russian Federation

1245.36.70009 Boehringer Ingelheim Investigational Site

๐Ÿ‡ท๐Ÿ‡บ

Moscow, Russian Federation

1245.36.63010 Boehringer Ingelheim Investigational Site

๐Ÿ‡ต๐Ÿ‡ญ

Tacloban, Philippines

1245.36.31012 Boehringer Ingelheim Investigational Site

๐Ÿ‡ณ๐Ÿ‡ฑ

Geleen, Netherlands

1245.36.35003 Boehringer Ingelheim Investigational Site

๐Ÿ‡ต๐Ÿ‡น

Faro, Portugal

1245.36.48006 Boehringer Ingelheim Investigational Site

๐Ÿ‡ต๐Ÿ‡ฑ

Gdansk, Poland

1245.36.48003 Boehringer Ingelheim Investigational Site

๐Ÿ‡ต๐Ÿ‡ฑ

Lodz, Poland

1245.36.48004 Boehringer Ingelheim Investigational Site

๐Ÿ‡ต๐Ÿ‡ฑ

Lodz, Poland

1245.36.48002 Boehringer Ingelheim Investigational Site

๐Ÿ‡ต๐Ÿ‡ฑ

Poznan, Poland

1245.36.10013 Boehringer Ingelheim Investigational Site

๐Ÿ‡บ๐Ÿ‡ธ

Dallas, Texas, United States

1245.36.20023 Boehringer Ingelheim Investigational Site

๐Ÿ‡จ๐Ÿ‡ฆ

Edmonton, Alberta, Canada

1245.36.20048 Boehringer Ingelheim Investigational Site

๐Ÿ‡จ๐Ÿ‡ฆ

Winnipeg, Manitoba, Canada

1245.36.20056 Boehringer Ingelheim Investigational Site

๐Ÿ‡จ๐Ÿ‡ฆ

Montreal, Quebec, Canada

1245.36.33040 Boehringer Ingelheim Investigational Site

๐Ÿ‡ซ๐Ÿ‡ท

Poitiers, France

1245.36.33038 Boehringer Ingelheim Investigational Site

๐Ÿ‡ซ๐Ÿ‡ท

Reims Cedex, France

1245.36.85206 Boehringer Ingelheim Investigational Site

๐Ÿ‡ญ๐Ÿ‡ฐ

Hong Kong, Hong Kong

1245.36.85202 Boehringer Ingelheim Investigational Site

๐Ÿ‡ญ๐Ÿ‡ฐ

Kowloon, Hong Kong

1245.36.91202 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฎ๐Ÿ‡ณ

Bangalore, India

1245.36.10018 Boehringer Ingelheim Investigational Site

๐Ÿ‡บ๐Ÿ‡ธ

Honolulu, Hawaii, United States

1245.36.20052 Boehringer Ingelheim Investigational Site

๐Ÿ‡จ๐Ÿ‡ฆ

Calgary, Alberta, Canada

1245.36.91214 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฎ๐Ÿ‡ณ

Chennai, India

1245.36.91210 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฎ๐Ÿ‡ณ

Mangalore, India

1245.36.91215 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฎ๐Ÿ‡ณ

Mumbai, Maharastra, India

1245.36.10005 Boehringer Ingelheim Investigational Site

๐Ÿ‡บ๐Ÿ‡ธ

Bethlehem, Pennsylvania, United States

1245.36.10015 Boehringer Ingelheim Investigational Site

๐Ÿ‡บ๐Ÿ‡ธ

Shreveport, Louisiana, United States

1245.36.91212 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฎ๐Ÿ‡ณ

New Delhi, India

1245.36.91216 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฎ๐Ÿ‡ณ

Nasik, India

1245.36.60006 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฒ๐Ÿ‡พ

Kelantan Kota Bahru, Malaysia

1245.36.60003 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฒ๐Ÿ‡พ

Johor Baru, Malaysia

1245.36.10009 Boehringer Ingelheim Investigational Site

๐Ÿ‡บ๐Ÿ‡ธ

West Palm Beach, Florida, United States

1245.36.44010 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฌ๐Ÿ‡ง

Birmingham, United Kingdom

1245.36.20054 Boehringer Ingelheim Investigational Site

๐Ÿ‡จ๐Ÿ‡ฆ

Calgary, Alberta, Canada

1245.36.33036 Boehringer Ingelheim Investigational Site

๐Ÿ‡ซ๐Ÿ‡ท

Paris, France

1245.36.33037 Boehringer Ingelheim Investigational Site

๐Ÿ‡ซ๐Ÿ‡ท

Reims, France

1245.36.60009 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฒ๐Ÿ‡พ

Kuala Lumpur, Malaysia

1245.36.60005 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฒ๐Ÿ‡พ

Kuala Lumpur, Malaysia

1245.36.60007 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฒ๐Ÿ‡พ

Perak, Malaysia

1245.36.60008 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฒ๐Ÿ‡พ

Sabah, Malaysia

1245.36.31015 Boehringer Ingelheim Investigational Site

๐Ÿ‡ณ๐Ÿ‡ฑ

Amersfoort, Netherlands

1245.36.60001 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฒ๐Ÿ‡พ

Selangor Darul Ehsan, Malaysia

1245.36.31009 Boehringer Ingelheim Investigational Site

๐Ÿ‡ณ๐Ÿ‡ฑ

Maastricht, Netherlands

1245.36.31002 Boehringer Ingelheim Investigational Site

๐Ÿ‡ณ๐Ÿ‡ฑ

Utrecht, Netherlands

1245.36.31003 Boehringer Ingelheim Investigational Site

๐Ÿ‡ณ๐Ÿ‡ฑ

Zaandam, Netherlands

1245.36.63008 Boehringer Ingelheim Investigational Site

๐Ÿ‡ต๐Ÿ‡ญ

Cavite City, Philippines

1245.36.63006 Boehringer Ingelheim Investigational Site

๐Ÿ‡ต๐Ÿ‡ญ

Cebu, Philippines

1245.36.63005 Boehringer Ingelheim Investigational Site

๐Ÿ‡ต๐Ÿ‡ญ

Manila, Philippines

1245.36.63009 Boehringer Ingelheim Investigational Site

๐Ÿ‡ต๐Ÿ‡ญ

Marikina, Philippines

1245.36.63007 Boehringer Ingelheim Investigational Site

๐Ÿ‡ต๐Ÿ‡ญ

Manila, Philippines

1245.36.48007 Boehringer Ingelheim Investigational Site

๐Ÿ‡ต๐Ÿ‡ฑ

Ruda Slaska, Poland

1245.36.48001 Boehringer Ingelheim Investigational Site

๐Ÿ‡ต๐Ÿ‡ฑ

Lublin, Poland

1245.36.35004 Boehringer Ingelheim Investigational Site

๐Ÿ‡ต๐Ÿ‡น

Lisboa, Portugal

1245.36.35002 Boehringer Ingelheim Investigational Site

๐Ÿ‡ต๐Ÿ‡น

Lisboa, Portugal

1245.36.35001 Boehringer Ingelheim Investigational Site

๐Ÿ‡ต๐Ÿ‡น

Vila Nova de Gaia, Portugal

1245.36.70011 Boehringer Ingelheim Investigational Site

๐Ÿ‡ท๐Ÿ‡บ

Moscow, Russian Federation

1245.36.70004 Boehringer Ingelheim Investigational Site

๐Ÿ‡ท๐Ÿ‡บ

St. Petersburg, Russian Federation

1245.36.70006 Boehringer Ingelheim Investigational Site

๐Ÿ‡ท๐Ÿ‡บ

St. Petersburg, Russian Federation

1245.36.70002 Boehringer Ingelheim Investigational Site

๐Ÿ‡ท๐Ÿ‡บ

Vsevolozhsk, Russian Federation

1245.36.74013 Boehringer Ingelheim Investigational Site

๐Ÿ‡ธ๐Ÿ‡ฐ

Nitra, Slovakia

1245.36.74011 Boehringer Ingelheim Investigational Site

๐Ÿ‡ธ๐Ÿ‡ฐ

Moldava nad Bodvou, Slovakia

1245.36.74007 Boehringer Ingelheim Investigational Site

๐Ÿ‡ธ๐Ÿ‡ฐ

Trencin, Slovakia

1245.36.74009 Boehringer Ingelheim Investigational Site

๐Ÿ‡ธ๐Ÿ‡ฐ

Zilina, Slovakia

1245.36.76020 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฟ๐Ÿ‡ฆ

Somerset West, South Africa

1245.36.76021 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฟ๐Ÿ‡ฆ

Plumstead, South Africa

1245.36.76022 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฟ๐Ÿ‡ฆ

Somerset West, South Africa

1245.36.34015 Boehringer Ingelheim Investigational Site

๐Ÿ‡ช๐Ÿ‡ธ

Barcelona, Spain

1245.36.34009 Boehringer Ingelheim Investigational Site

๐Ÿ‡ช๐Ÿ‡ธ

Granada, Spain

1245.36.34014 Boehringer Ingelheim Investigational Site

๐Ÿ‡ช๐Ÿ‡ธ

L'Hospitalet de Llobregat, Spain

1245.36.34012 Boehringer Ingelheim Investigational Site

๐Ÿ‡ช๐Ÿ‡ธ

Madrid, Spain

1245.36.34013 Boehringer Ingelheim Investigational Site

๐Ÿ‡ช๐Ÿ‡ธ

Madrid, Spain

1245.36.34019 Boehringer Ingelheim Investigational Site

๐Ÿ‡ช๐Ÿ‡ธ

Valencia, Spain

1245.36.34020 Boehringer Ingelheim Investigational Site

๐Ÿ‡ช๐Ÿ‡ธ

Manresa, Spain

1245.36.34017 Boehringer Ingelheim Investigational Site

๐Ÿ‡ช๐Ÿ‡ธ

Valencia, Spain

1245.36.34016 Boehringer Ingelheim Investigational Site

๐Ÿ‡ช๐Ÿ‡ธ

Santiago de Compostela, Spain

1245.36.44013 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฌ๐Ÿ‡ง

Blackpool, United Kingdom

1245.36.44018 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฌ๐Ÿ‡ง

Bath, United Kingdom

1245.36.44025 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฌ๐Ÿ‡ง

Doncaster, United Kingdom

1245.36.44026 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฌ๐Ÿ‡ง

Chester, United Kingdom

1245.36.44036 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฌ๐Ÿ‡ง

Epsom, United Kingdom

1245.36.44001 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฌ๐Ÿ‡ง

Frome, United Kingdom

1245.36.44023 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฌ๐Ÿ‡ง

Nantwich, United Kingdom

1245.36.44007 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฌ๐Ÿ‡ง

Midsomer Norton, United Kingdom

1245.36.44024 Boehringer Ingelheim Investigational Site

๐Ÿ‡ฌ๐Ÿ‡ง

Welwyn Garden City, United Kingdom

1245.36.10019 Boehringer Ingelheim Investigational Site

๐Ÿ‡บ๐Ÿ‡ธ

Lomita, California, United States

1245.36.85204 Boehringer Ingelheim Investigational Site

๐Ÿ‡ญ๐Ÿ‡ฐ

Hong Kong, Hong Kong

1245.36.85205 Boehringer Ingelheim Investigational Site

๐Ÿ‡ญ๐Ÿ‡ฐ

Hong Kong, Hong Kong

ยฉ Copyright 2025. All Rights Reserved by MedPath